BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021;36:101051. [PMID: 33519949 DOI: 10.1016/j.nantod.2020.101051] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Jermy BR, Ravinayagam V, Almohazey D, Alamoudi WA, Dafalla H, Akhtar S, Tanimu G. PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19. Appl Clay Sci 2021;:106333. [PMID: 34776567 DOI: 10.1016/j.clay.2021.106333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Anand U, Jakhmola S, Indari O, Jha HC, Chen ZS, Tripathi V, Pérez de la Lastra JM. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update. Front Immunol 2021;12:658519. [PMID: 34276652 DOI: 10.3389/fimmu.2021.658519] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD, Truong NP. Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines. Vaccines (Basel) 2021;9:359. [PMID: 33918072 DOI: 10.3390/vaccines9040359] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 17.0] [Reference Citation Analysis]
4 Noor N, Gani A, Gani A, Shah A, Ashraf ZU. Exploitation of polyphenols and proteins using nanoencapsulation for anti-viral and brain boosting properties - Evoking a synergistic strategy to combat COVID-19 pandemic. Int J Biol Macromol 2021;180:375-84. [PMID: 33716131 DOI: 10.1016/j.ijbiomac.2021.03.028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Hwang SR, Chakraborty K, An JM, Mondal J, Yoon HY, Lee YK. Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy. Pharmaceutics 2021;13:1875. [PMID: 34834290 DOI: 10.3390/pharmaceutics13111875] [Reference Citation Analysis]
6 Sharma S. Role of nanomedicine in COVID-19 therapeutics. Nanomedicine (Lond) 2022. [PMID: 35012366 DOI: 10.2217/nnm-2021-0358] [Reference Citation Analysis]
7 Seo YB, Suh YS, Ryu JI, Jang H, Oh H, Koo BS, Seo SH, Hong JJ, Song M, Kim SJ, Sung YC. Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates. Vaccines (Basel) 2021;9:307. [PMID: 33804981 DOI: 10.3390/vaccines9040307] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 Shi Y, Qian H, Rao P, Mu D, Liu Y, Liu G, Lin Z. Bioinspired membrane-based nanomodulators for immunotherapy of autoimmune and infectious diseases. Acta Pharm Sin B 2022;12:1126-47. [PMID: 35530145 DOI: 10.1016/j.apsb.2021.09.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alblehai F, Mahmoud MH, Akhtar MS, Shaker A, Mohamed AA. Analysing biosensor clinical pathogen information using mayfly optimized convolute neural network approach. Expert Systems. [DOI: 10.1111/exsy.13027] [Reference Citation Analysis]
10 Wang D, Zhang B, Ding H, Liu D, Xiang J, Gao XJ, Chen X, Li Z, Yang L, Duan H, Zheng J, Liu Z, Jiang B, Liu Y, Xie N, Zhang H, Yan X, Fan K, Nie G. TiO2 supported single Ag atoms nanozyme for elimination of SARS-CoV2. Nano Today 2021;40:101243. [PMID: 34249143 DOI: 10.1016/j.nantod.2021.101243] [Reference Citation Analysis]
11 Hallan SS, Sguizzato M, Esposito E, Cortesi R. Challenges in the Physical Characterization of Lipid Nanoparticles. Pharmaceutics 2021;13:549. [PMID: 33919859 DOI: 10.3390/pharmaceutics13040549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Silveira CP, Schneid ADC, Ribeiro IRS, Galdino FE, Cardoso MB. A nano perspective behind the COVID-19 pandemic. Nanoscale Horiz 2021. [PMID: 34382995 DOI: 10.1039/d1nh00135c] [Reference Citation Analysis]
13 Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
14 Hufnagel M, Neuberger R, Wall J, Link M, Friesen A, Hartwig A. Impact of Differentiated Macrophage-Like Cells on the Transcriptional Toxicity Profile of CuO Nanoparticles in Co-Cultured Lung Epithelial Cells. Int J Mol Sci 2021;22:5044. [PMID: 34068728 DOI: 10.3390/ijms22095044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Khandker SS, Godman B, Jawad MI, Meghla BA, Tisha TA, Khondoker MU, Haq MA, Charan J, Talukder AA, Azmuda N, Sharmin S, Jamiruddin MR, Haque M, Adnan N. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines (Basel) 2021;9:1387. [PMID: 34960133 DOI: 10.3390/vaccines9121387] [Reference Citation Analysis]
16 Lee JW, Chun W, Lee HJ, Min JH, Kim SM, Seo JY, Ahn KS, Oh SR. The Role of Macrophages in the Development of Acute and Chronic Inflammatory Lung Diseases. Cells 2021;10:897. [PMID: 33919784 DOI: 10.3390/cells10040897] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tragni V, Preziusi F, Laera L, Onofrio A, Mercurio I, Todisco S, Volpicella M, De Grassi A, Pierri CL. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context. EPMA J 2022;:1-27. [PMID: 35013687 DOI: 10.1007/s13167-021-00267-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
18 Wu D, Yang XO. Dysregulation of Pulmonary Responses in Severe COVID-19. Viruses 2021;13:957. [PMID: 34064104 DOI: 10.3390/v13060957] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Gurianov V, Rorat M. Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome. Viruses 2021;13:1067. [PMID: 34205217 DOI: 10.3390/v13061067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Niza E, Ocaña A, Castro-Osma JA, Bravo I, Alonso-Moreno C. Polyester Polymeric Nanoparticles as Platforms in the Development of Novel Nanomedicines for Cancer Treatment. Cancers (Basel) 2021;13:3387. [PMID: 34298604 DOI: 10.3390/cancers13143387] [Reference Citation Analysis]
21 Makdasi E, Levy Y, Alcalay R, Noy-Porat T, Zahavy E, Mechaly A, Epstein E, Peretz E, Cohen H, Bar-On L, Chitlaru T, Cohen O, Glinert I, Achdout H, Israely T, Rosenfeld R, Mazor O. Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope. Viruses 2021;13:566. [PMID: 33810465 DOI: 10.3390/v13040566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Albaz AA, Rafeeq MM, Sain ZM, Almutairi WA, Alamri AS, Aloufi AH, Almalki WH, Tarique M. Nanotechnology-based approaches in the fight against SARS-CoV-2. AIMS Microbiol 2021;7:368-98. [PMID: 35071938 DOI: 10.3934/microbiol.2021023] [Reference Citation Analysis]
23 Saksena N, Bonam SR, Miranda-Saksena M. Epigenetic Lens to Visualize the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection in COVID-19 Pandemic. Front Genet 2021;12:581726. [PMID: 33828579 DOI: 10.3389/fgene.2021.581726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
24 Yang S, Wallach M, Krishna A, Kurmasheva R, Sridhar S. Recent Developments in Nanomedicine for Pediatric Cancer. J Clin Med 2021;10:1437. [PMID: 33916177 DOI: 10.3390/jcm10071437] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Donofrio G, Franceschi V, Macchi F, Russo L, Rocci A, Marchica V, Costa F, Giuliani N, Ferrari C, Missale G. A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay. Vaccines (Basel) 2021;9:389. [PMID: 33920999 DOI: 10.3390/vaccines9040389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
26 Wang Y, Hao Y, Fa S, Zheng W, Yuan C, Wang W. Nanomedicine for the Diagnosis and Therapy of COVID-19. Front Bioeng Biotechnol 2021;9:758121. [PMID: 34805116 DOI: 10.3389/fbioe.2021.758121] [Reference Citation Analysis]
27 Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Olusanya OA, Bednarczyk RA, Davis RL, Shaban-Nejad A. Addressing Parental Vaccine Hesitancy and Other Barriers to Childhood/Adolescent Vaccination Uptake During the Coronavirus (COVID-19) Pandemic. Front Immunol 2021;12:663074. [PMID: 33815424 DOI: 10.3389/fimmu.2021.663074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yan ZP, Yang M, Lai CL. COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials. Pharmaceuticals (Basel) 2021;14:406. [PMID: 33923054 DOI: 10.3390/ph14050406] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
30 Hafez Ghoran S, El-Shazly M, Sekeroglu N, Kijjoa A. Natural Products from Medicinal Plants with Anti-Human Coronavirus Activities. Molecules 2021;26:1754. [PMID: 33800977 DOI: 10.3390/molecules26061754] [Reference Citation Analysis]
31 da Silva-neto PV, do Valle VB, Fuzo CA, Fernandes TM, Toro DM, Fraga-silva TFC, Basile PA, de Carvalho JCS, Pimentel VE, Pérez MM, Oliveira CNS, Rodrigues LC, Bastos VAF, Tella SOC, Martins RB, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Vilar FC, Gaspar GG, Rocha JJRD, Feres O, Arruda E, Maruyama SR, Russo EMS, Viana AL, Santos IKFM, Bonato VLD, Cardoso CRB, Tanus-santos JE, Donadi EA, Faccioli LH, Dias-baruffi M, Fernandes APM, Gerlach RF, Sorgi CA; on behalf of the IMMUNOCOVID Study Group. Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. Biomolecules 2022;12:604. [DOI: 10.3390/biom12050604] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]